These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2790041)

  • 1. Platelet-activating factor induces the production of leukotrienes by human monocytes.
    Fauler J; Sielhorst G; Frölich JC
    Biochim Biophys Acta; 1989 Sep; 1013(1):80-5. PubMed ID: 2790041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties.
    Gilfillan AM; Wiggan GA; Hope WC; Patel BJ; Welton AF
    Eur J Pharmacol; 1990 Feb; 176(3):255-62. PubMed ID: 1691711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
    Brunelleschi S; Renzi D; Ledda F; Giotti A; Fantozzi R; Brink C; Benveniste J
    Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages.
    Thivierge M; Rola-Pleszczynski M
    J Allergy Clin Immunol; 1992 Nov; 90(5):796-802. PubMed ID: 1331218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
    Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S; Thériault P; Lauzière M; Braquet P; Sirois P
    Br J Pharmacol; 1989 Jan; 96(1):153-62. PubMed ID: 2538179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism.
    Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC
    J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
    Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
    Kecskeméti V; Balogh I
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of platelet-activating factor (PAF-acether) to induce decidualization in mice and failure of antagonists of PAF to inhibit implantation.
    Milligan SR; Finn CA
    J Reprod Fertil; 1990 Jan; 88(1):105-12. PubMed ID: 2313629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
    de Lima WT; Sirois P; Jancar S
    Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
    Földes-Filep E; Braquet P; Filep J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.